Shareholders Equity: The sum of preferred and common equity items.
Editas Medicine, Inc. (EDIT) had Shareholders Equity of $27.29M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$40.52M |
|
$-160.06M |
|
-- |
|
$40.52M |
|
$200.53M |
|
$-160.01M |
|
$-0.05M |
|
$-160.06M |
|
$-160.06M |
|
$-160.06M |
|
$-160.06M |
|
$-160.06M |
|
$-160.06M |
|
$-160.01M |
|
$-155.63M |
|
88.75M |
|
88.75M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$163.90M |
|
$3.54M |
|
$22.64M |
|
$186.53M |
|
$46.25M |
|
-- |
|
$113.00M |
|
$159.25M |
|
$27.29M |
|
$27.29M |
|
|
Shareholders Equity |
$27.29M |
97.87M |
|
| Cash Flow Statement Financials | |
$-165.24M |
|
$138.67M |
|
$40.47M |
|
$135.42M |
|
$149.31M |
|
$13.90M |
|
$10.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-394.89% |
|
-394.89% |
|
-384.09% |
|
-395.01% |
|
-395.01% |
|
$-165.58M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
2.67 |
|
136.70 |
|
-586.56% |
|
-586.56% |
|
-85.81% |
|
-586.56% |
|
$0.28 |
|
$-1.87 |
|
$-1.86 |
|